Trial Profile
A phase II trial of rosuvastatin in patients with dyslipidaemia and type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 06 Dec 2015 New trial record